Skip to main content
OGN logo
OGN
(NYSE)
Organon & Co.
$6.36-- (--)
Loading... - Market loading

Organon & Co. (OGN) Stock Price & Financial Analysis

Organon & Co. Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.95 - $6.37
52-Week High$14.76
52-Week Low$5.69
Open$6.04
Volume3.40M
Average Volume (3M)3.40M
Market Cap1.66B
Shares Outstanding260.76M
P/E Ratio (TTM)8.56
Forward P/E17.08
Price to Sales (P/S)0.26
Price to Book (P/B)2.13
EV/EBITDA7.65
Revenue (TTM)6.22B
Net Income (TTM)187.00M
Free Cash Flow (TTM)404.00M
EPS (TTM)$0.72
Profit Margin3.01%
Operating Margin20.01%
Return on Equity (ROE)24.87%
Debt to Equity11.72
50-Day MA$7.32
200-Day MA$8.49
52-Week Change-56.55%
Annual Dividend$0.08
Dividend Yield1.30%
Payout Ratio11.13%
Last Dividend Ex-DateFeb 23, 2026

Frequently Asked Questions About Organon & Co.

What is the current stock price for OGN?

As of the latest trading session, OGN stock trades at $6.36. The 52-week range is $5.69–$14.76, with a day range of $5.95–$6.37.

What is the P/E ratio for OGN?

Organon & Co.'s trailing P/E ratio is 8.6, meaning investors pay $8.6 for every $1 of annual earnings. The forward P/E is 17.1, reflecting analyst expectations for future earnings. Organon & Co. operates in the Healthcare sector.

Does OGN pay dividends?

Yes, Organon & Co. pays a 1.30% annual dividend yield ($0.08 per share). The payout ratio is 11.1%. The last ex-dividend date was 2026-02-23.

What do analysts recommend for OGN?

Based on 1 analyst, the consensus for OGN is Sell. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of OGN?

Organon & Co.'s market capitalization is $1.66B, classifying it as a small-cap company. Organon & Co. operates in the Healthcare sector within the Drug Manufacturers - General industry.